☰ Accessibility

Manali Petrochemicals:
Subsidiary AMCHEM signs a share purchase agreement with Coim S.p.A. to sell its entire stake in Notedome Ltd, UK, as part of its global portfolio rebalancing.

Ola Electric Mobility:
Clarifies that no chargesheet has been filed in the ongoing investigation and reiterates full cooperation with authorities.

Dr Reddy’s Laboratories:
Receives Establishment Inspection Report (EIR) from the US FDA with a “Voluntary Action Indicated” (VAI) classification for its Andhra Pradesh facility, marking a satisfactory inspection closure.

Federal Bank:
Denies reports of a board decision on a preferential issue for a 9.99% stake, stating no such proposal has been finalised.

Expleo Solutions:
Approves the closure of its Competence Centre in Coimbatore to optimise operational efficiency; closure date to be announced later.

Gulshan Polyols:
Secures a ₹1,185 crore order to supply ethanol to Oil Marketing Companies (OMCs) under the Ethanol Blended Petrol Programme, reinforcing its leadership in green fuels.

Lloyds Metals & Energy:
Approves the allotment of 19.6 lakh shares at ₹1,460.5 per share, raising ₹286 crore from Adler Industrial Services to support expansion initiatives.

Filatex India:
Partners with Revti Business and Wastewear through an MoU to collaborate on textile recycling, innovation, and sustainable manufacturing.

Rubicon Research:
Wholly owned subsidiary Advagen Holdings enters an agreement with GEn1E Lifesciences Inc. to acquire Series Prime Preferred Stock for up to $3 million, expanding its U.S. biotech investments.

Disclaimer:

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.